Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-03-23 Purchase | 2021-03-23 3:57 pm | Cardiff Oncology Inc. | CRDF | JACOB GARY S Director | 2,370 | $10.42 | $24,689 | 21,922 (Direct) | View |
| 2021-02-17 Purchase | 2021-02-19 6:22 pm | Virpax Pharmaceuticals Inc. | VRPX | JACOB GARY S Director | 3,500 | $6.789 | $23,762 | 3,500 (Direct) | View |
| 2020-12-01 Purchase | 2020-12-01 7:53 pm | Hepion Pharmaceuticals Inc. | HEPA | JACOB GARY S Director | 12,000 | $1.66 | $19,920 | 12,059 (Direct) | View |
| 2020-05-14 Purchase | 2020-05-18 4:16 pm | Cardiff Oncology Inc. | CRDF | JACOB GARY S Director | 17,483 | $1.43 | $25,001 | 19,552 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-19 Option Award | 2024-02-21 8:01 pm | 2024-02-19 2026-02-19 | Hepion Pharmaceuticals Inc. | HEPA | JACOB GARY S Director | 85,000 | $0 | 102,120 (Direct) | View |
Ownership | 2022-05-16 5:44 pm | N/A 2029-01-06 | OKYO Pharma Ltd | OKYO | JACOB GARY S Chief Executive Officer | 0 | $0 | 53,000,000 (Direct) | View |
| 2022-01-01 Option Award | 2022-01-05 5:18 pm | 2023-01-01 2032-01-01 | Virpax Pharmaceuticals Inc. | VRPX | JACOB GARY S Director | 12,091 | $0 | 12,091 (Direct) | View |
| 2021-06-10 Other | 2021-06-15 10:06 am | 2021-06-10 2023-06-10 | Cardiff Oncology Inc. | CRDF | JACOB GARY S Former Director Director | 75,834 | $0 | 608,848 (Direct) | View |
| 2021-05-18 Option Award | 2021-05-20 4:36 pm | 2022-05-18 2031-05-18 | Hepion Pharmaceuticals Inc. | HEPA | JACOB GARY S Director | 250,000 | $0 | 342,785 (Direct) | View |
| 2021-04-07 Option Award | 2021-04-09 5:00 pm | 2022-04-07 2031-04-07 | Virpax Pharmaceuticals Inc. | VRPX | JACOB GARY S Director | 13,183 | $0 | 13,183 (Direct) | View |
Ownership | 2021-02-16 7:06 pm | 2021-04-26 2030-04-26 | Virpax Pharmaceuticals Inc. | VRPX | JACOB GARY S Director | 0 | $0 | 20,225 (Direct) | View |
| 2020-08-19 Option Award | 2020-08-21 4:15 pm | 2021-08-19 2030-08-19 | Hepion Pharmaceuticals Inc. | HEPA | JACOB GARY S Director | 30,000 | $0 | 92,785 (Direct) | View |
| 2020-06-17 Option Award | 2020-06-19 4:16 pm | 2021-06-17 2030-06-17 | Cardiff Oncology Inc. | CRDF | JACOB GARY S Director | 28,858 | $0 | 76,106 (Direct) | View |
| 2020-04-03 Option Award | 2020-04-07 4:13 pm | 2021-04-03 2030-04-03 | Hepion Pharmaceuticals Inc. | HEPA | JACOB GARY S Director | 60,000 | $0 | 62,729 (Direct) | View |